Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Olivier J.F. Wouters, Ph.D.

Concepts (97)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Drug Industry1320247913.770 Why?
Drug Costs10202411942.190 Why?
Commerce520246121.950 Why?
Drug Approval520248191.830 Why?
Patents as Topic220241111.620 Why?
Lobbying22024321.600 Why?
Drugs, Generic520244571.510 Why?
Technology Assessment, Biomedical220243121.490 Why?
United States Food and Drug Administration8202416731.450 Why?
Costs and Cost Analysis7202216661.200 Why?
Research5202319741.100 Why?
Economic Competition220242230.910 Why?
Drugs, Essential12024710.890 Why?
Health Policy6202326990.840 Why?
Nebulizers and Vaporizers120231380.780 Why?
Albuterol120222110.750 Why?
Civil Defense120231140.750 Why?
Bronchodilator Agents120225130.620 Why?
Economics, Pharmaceutical12018880.600 Why?
Immunization Programs120212670.590 Why?
Politics220208210.530 Why?
Medical Savings Accounts12016340.520 Why?
Social Justice120204840.500 Why?
Biological Products120249470.490 Why?
Drug and Narcotic Control220171440.480 Why?
Disclosure120207560.460 Why?
Tropical Medicine12014520.430 Why?
Neglected Diseases12014670.430 Why?
Decision Support Systems, Clinical1202211760.420 Why?
National Health Programs220204430.420 Why?
Patient Care Management120153010.400 Why?
Medical Oncology1202423390.390 Why?
Cost Savings120179000.390 Why?
Developing Countries1202429130.390 Why?
Health Expenditures3202423880.380 Why?
Health Services Accessibility3202455090.370 Why?
Health Care Reform2202312570.370 Why?
United States172024729090.350 Why?
Medicare Part D220243550.320 Why?
Quality-Adjusted Life Years1201517400.310 Why?
Negotiating320241520.310 Why?
Artificial Intelligence1202226610.290 Why?
Benchmarking2202410550.290 Why?
Public Sector220182640.250 Why?
Europe4202334300.230 Why?
Insurance, Health1201625200.220 Why?
Medicare Part B120231150.200 Why?
Humans3120247659260.200 Why?
Pharmaceutical Preparations2202010840.200 Why?
South Africa2201818680.190 Why?
Renal Insufficiency, Chronic1201523070.180 Why?
Developed Countries120244520.180 Why?
Delivery of Health Care3202453640.170 Why?
Technology120222960.170 Why?
European Union120201570.160 Why?
State Medicine120202190.150 Why?
Resource Allocation120213540.150 Why?
World Health Organization1202413260.150 Why?
Health Facilities120225770.140 Why?
Legislation, Pharmacy1201630.140 Why?
Income1202418740.130 Why?
Private Sector120183960.120 Why?
Cyprus12015960.120 Why?
Singapore120162970.120 Why?
International Cooperation1202114330.110 Why?
Pandemics3202387210.110 Why?
China2202023830.110 Why?
Meta-Analysis as Topic2201713660.110 Why?
Disease Outbreaks1202317610.110 Why?
Deductibles and Coinsurance120163150.110 Why?
Financing, Personal120163100.110 Why?
Cost Sharing120154090.090 Why?
Cardiovascular Diseases12015156450.080 Why?
Medicare2202468150.080 Why?
Reimbursement Mechanisms120156690.080 Why?
Statistics as Topic1201523500.080 Why?
Biomedical Research1202434580.080 Why?
Patient Acceptance of Health Care1202132300.070 Why?
Drug Prescriptions1201516620.060 Why?
Evidence-Based Medicine1201736900.060 Why?
Time Factors22024400970.060 Why?
Anti-Bacterial Agents1202274730.060 Why?
Models, Theoretical1201535600.050 Why?
Hypoglycemic Agents1201531060.050 Why?
Feasibility Studies1201453000.050 Why?
Health Care Costs1201632410.050 Why?
Kidney Failure, Chronic1201525040.050 Why?
Cost-Benefit Analysis1201555310.050 Why?
Cross-Sectional Studies12022262820.050 Why?
Africa120217250.040 Why?
Comparative Effectiveness Research120247130.040 Why?
Disease Progression12015136140.040 Why?
Journal Impact Factor120151570.030 Why?
Diabetes Mellitus, Type 212015122350.020 Why?
Randomized Controlled Trials as Topic12017103800.010 Why?
Reproducibility of Results12015201330.010 Why?
Aged120231711630.010 Why?
Wouters's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (97)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.